SIRT2‐dependent IDH1 deacetylation inhibits colorectal cancer and liver metastases

Bo Wang(Sun Yat-sen University), Xin Yang(Cancer Genetics (United States)), Pauli Puolakkainen(University of Helsinki), Jianyuan Luo(Peking University), Shuaiyi Chen(Peking University), Hongpeng Jiang(Peking University), Yingjiang Ye(Peking University), Harri Mustonen(University of Helsinki), Boya Liu(Boston Children's Hospital), Shan Wang(University of Veterinary Medicine Hannover, Foundation), Zhe Wang(Peking University), Kewei Jiang(Peking University), Wei Zhang(Peking University)
EMBO Reports
March 5, 2020
10.15252/embr.201948183
Cited by 128

Related Papers

Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer
|Cell|2020|1.6k
Lineage tracking reveals dynamic relationships of T cells in colorectal cancer
|Nature|2018|1.5k
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
|The Lancet Oncology|2021|436
Mitochondrial dysfunction: roles in skeletal muscle atrophy
|Journal of Translational Medicine|2023|275
SHMT2 Desuccinylation by SIRT5 Drives Cancer Cell Proliferation
|Cancer Research|2017|237